Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872672 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 6 Pages |
Abstract
These results indicate that concomitant chemobrachyradiotherapy with ifosfamide and cisplatin is a feasible combination for patients with LASCC of the cervix uteri. A randomized trial is planned.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eduard M.D., Ph.D., Tomislav M.D., Tomislav M.D., Kristina M.D., Tihana M.D., Nives M.D., Stjepan M.D., Ph.D., Wolfgang M.D.,